Uncovering the Global Chronic Cough Market: Industry Analysis, Unleashing Future Demand and Forecast till 2032 || Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Chronic Cough Global Market Report 2023 identifies the rise in the prevalence of cough is the major driver for the chronic cough market's growth in the forecast period. Cough refers to a reflex action that, frequently in response to irritation, mucus, or foreign objects, helps clear the airways by ejecting air forcefully from the lungs. A persistent cough that lasts for at least eight weeks is considered chronic. Therefore, when the incidence of cough rises, so do the cases of chronic cough. For instance, in March 2022, according to the Florida Health, a US-based Department of Healthcare, in the US total of 2,390 cases of whooping cough were found in 2020, and 80 patients were found in 2021, for incidences of 41.0 and 1.4 per 100,000 years, respectively. There were 28 pertussis cases recorded in 2023 among 13 countries.

The global chronic cough market is expected to grow from $6.88 billion in 2022 to $7.50 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chronic cough market is expected to reach $10.43 billion in 2027 at a CAGR of 8.6%.

Download Free Sample Of Chronic Cough Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp

Major competitors in the chronic cough market are Tris Pharma Inc.; Pfizer Inc.; Johnson & Johnson Co; Bayer AG; Novartis AG; Sanofi SA; Bristol-Myers Squibb Company; AstraZeneca plc; Glaxo SmithKline Plc; Merck KGaA; Reckitt Benckiser Group plc; Glenmark Pharmaceuticals Ltd; Teva Pharmaceutical Industries Ltd.; Mylan NV.

A key trend in the chronic cough market includes product innovations. Major companies operating in the chronic cough market are concentrating on creating innovative products to strengthen their position in the market. For instance, in October 2020, GSK Consumer Healthcare, a UK-based pharmaceutical and biotechnology company, launched Robitussin Naturals, a drug-free product that relieves occasional long-term cough. Robitussin users and proponents of natural wellness products are made with natural components to give people confidence in their solutions to treat spasmodic coughs.

Read More On The Global Chronic Cough Market Report Here:
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report

The chronic cough market is segmented -

1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes

2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route of Administrations

3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

5) By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the chronic cough market.

The Business Research Company's "Global Chronic Cough Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Chronic Cough Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12109

The Table Of Content For The Chronic Cough Market Include:
1. Executive Summary
2. Chronic Cough Market Characteristics
3. Chronic Cough Market Trends And Strategies
4. Chronic Cough Market - Macro Economic Scenario
5. Chronic Cough Market Size And Growth
……………
27. Chronic Cough Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Chronic Cough Market
29. Chronic Cough Market Future Outlook And Potential Analysis
30. Appendix

Contact us:

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.